Title

Immunotherapy for the Treatment of Hematologic Malignancies: Multiple Myeloma, Lymphoma, and Acute Leukemia

Authoring Organization

Society for Immunotherapy of Cancer

Publication Month/Year

December 20, 2016

Last Updated Month/Year

January 16, 2024

Supplemental Implementation Tools

Document Type

Consensus

External Publication Status

Update_in_progress

Country of Publication

US

Inclusion Criteria

Male, Female, Adult, Older adult

Health Care Settings

Ambulatory, Outpatient

Intended Users

Nurse, nurse practitioner, physician, physician assistant

Scope

Treatment, Management

Diseases/Conditions (MeSH)

D008223 - Lymphoma, D007938 - Leukemia, D009101 - Multiple Myeloma

Keywords

multiple myeloma, hematologic malignancies, lymphoma, acute leukemia

Source Citation

Boyiadzis M, Bishop MR, Abonour R, et al; The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia; Journal for ImmunoTherapy of Cancer 2016;4:90. doi: 10.1186/s40425-016-0188-z

Supplemental Methodology Resources

Data Supplement, Data Supplement